Inger Birgitta Fogelberg

Commercial Services

Consumer Services

Health Technology

Profile

Inger Birgitta Fogelberg worked as a Director at Visionar Preclinical AB from 2000 to 2011 and as a Principal at Pharmacia AB from 1984 to 1994.
She also held a Principal position at the University of Uppsala.

Former positions of Inger Birgitta Fogelberg

Companies	Position	End
Visionar Preclinical AB Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials.	Director/Board Member	20/11/2011
Pharmacia AB	Corporate Officer/Principal	31/12/1993
University of Uppsala	Corporate Officer/Principal	-

See the detail of Inger Birgitta Fogelberg's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Inger Birgitta Fogelberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Visionar Preclinical AB Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials.	Commercial Services
Pharmacia AB	Health Technology